Pediatrix Medical Group (NYSE:MD) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Pediatrix Medical Group (NYSE:MD) from a sell rating to a hold rating in a research report released on Wednesday.

Several other analysts have also recently commented on the stock. Truist Financial reiterated a hold rating and set a $10.00 target price on shares of Pediatrix Medical Group in a research report on Wednesday, May 15th. Deutsche Bank Aktiengesellschaft upgraded shares of Pediatrix Medical Group from a sell rating to a hold rating and set a $8.00 target price for the company in a research report on Friday, June 7th. Six research analysts have rated the stock with a hold rating, Based on data from MarketBeat, the company presently has an average rating of Hold and an average price target of $9.10.

Pediatrix Medical Group Trading Up 2.6 %

MD stock opened at $7.40 on Wednesday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.72 and a current ratio of 1.72. The company has a 50 day moving average price of $7.53 and a 200 day moving average price of $8.68. Pediatrix Medical Group has a fifty-two week low of $6.62 and a fifty-two week high of $15.02.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.17 earnings per share for the quarter, topping the consensus estimate of $0.15 by $0.02. The firm had revenue of $495.10 million during the quarter, compared to analysts’ expectations of $496.25 million. Pediatrix Medical Group had a negative net margin of 3.53% and a positive return on equity of 10.31%. Equities research analysts anticipate that Pediatrix Medical Group will post 1.13 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Pediatrix Medical Group

Large investors have recently modified their holdings of the business. Boston Partners bought a new stake in shares of Pediatrix Medical Group in the fourth quarter worth about $12,452,000. Clark Estates Inc. NY bought a new stake in shares of Pediatrix Medical Group in the fourth quarter worth about $3,302,000. Pacer Advisors Inc. increased its holdings in shares of Pediatrix Medical Group by 126.9% in the fourth quarter. Pacer Advisors Inc. now owns 3,235,729 shares of the company’s stock worth $30,092,000 after acquiring an additional 1,809,828 shares in the last quarter. Connable Office Inc. bought a new stake in shares of Pediatrix Medical Group in the fourth quarter worth about $217,000. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Pediatrix Medical Group by 10.0% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,634,065 shares of the company’s stock worth $15,197,000 after acquiring an additional 148,600 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.